HL427

N/A

Report date: 2024/11/05 14:28:31

Base Information

Drug NameHL427
Drug Alias NameHL427HL-427
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Alpha-enolase
TargetsAlpha-enolase
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHuniLife Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesHuniLife Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A